Evaluation of in vivo genotoxicity induced by N-ethyl-N-nitrosourea, benzo[a]pyrene, and 4-nitroquinoline-1-oxide in the Pig-a and gpt assays

Environmental and Molecular Mutagenesis

Volumn 54, Issue 9, 2013, Pages 747-754

  Horibata, Katsuyoshi ^a   Ukai, Akiko ^a   Kimoto, Takafumi ^b   Suzuki, Tetsuya ^a   Kamoshita, Nagisa ^a   Masumura, Kenichi ^a   Nohmi, Takehiko ^a   Honma, Masamitsu ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b TEIJIN PHARMA LIMITED   (Japan)

Author keywords

Genotoxicity; Glycosylphosphatidylinositol anchor; Red blood cells; Transgenic rodent mutation assays

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; BENZO[A]PYRENE; ETHYLNITROSOUREA; GLYCOSYLPHOSPHATIDYLINOSITOL; GPT DELTA PROTEIN; PIG A PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; ERYTHROCYTE; FLOW CYTOMETRY; GENE FREQUENCY; GENE MUTATION; GENOTOXICITY; IN VIVO STUDY; LIVER; MOUSE; NONHUMAN; PROTEIN DETERMINATION; SAMPLING; TOXICOLOGY;

GENOTOXICITY; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR; RED BLOOD CELLS; TRANSGENIC RODENT MUTATION ASSAYS;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; BENZO(A)PYRENE; BIOLOGICAL ASSAY; DNA DAMAGE; ERYTHROCYTES; ESCHERICHIA COLI PROTEINS; ETHYLNITROSOUREA; FLOW CYTOMETRY; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTAGENICITY TESTS; MUTAGENS; MUTATION; PENTOSYLTRANSFERASES;

ANIMALIA; MUS; RODENTIA; SUIDAE;

EID: 84887182267     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21818     Document Type: Article

References (29)

1. Bhalli JA, Pearce MG, Dobrovolsky VN, Heflich RH. 2011a. Manifestation and persistence of Pig-a mutant red blood cells in C57BL/6 mice following single and split doses of N-ethyl-N-nitrosourea. Environ Mol Mutagen 52:766-773.
2. Bhalli JA, Shaddock JG, Pearce MG, Dobrovolsky VN, Cao X, Heflich RH, Vohr H-W. 2011b. Report on stage III Pig-a mutation assays using benzo[a]pyrene. Environ Mol Mutagen 52:731-737.
3. Cammerer Z, Bhalli JA, Cao X, Coffing SL, Dickinson D, Dobo KL, Dobrovolsky VN, Engel M, Fiedler RD, Gunther WC, Heflich RH, Pearce MG, Shaddock JG, Shutsky T, Thiffeault CJ, Schuler M. 2011. Report on stage III Pig-a mutation assays using N-ethyl-N-nitrosourea-Comparison with other in vivo genotoxicity endpoints. Environ Mol Mutagen 52:721-730.
4. COM. 2011. Guidance on a strategy for genotoxicity testing of chemical substances.: Committee on mutagenicity of chemicals in food, consumers products, and the environment (COM).
5. Dertinger SD, Phonethepswath S, Franklin D, Weller P, Torous DK, Bryce SM, Avlasevich S, Bemis JC, Hyrien O, Palis J, MacGregor JT. 2010. Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies. Toxicol Sci 115:401-411.
6. Dertinger SD, Phonethepswath S, Weller P, Avlasevich S, Torous DK, Mereness JA, Bryce SM, Bemis JC, Bell S, Portugal S, Aylott M, MacGregor JT. 2011. Interlaboratory Pig-a gene mutation assay trial: Studies of 1, 3-propane sultone with immunomagnetic enrichment of mutant erythrocytes. Environ Mol Mutagen 52:748-755.
7. Dobrovolsky VN, Miura D, Heflich RH, Dertinger SD. 2010. The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment. Environ Mol Mutagen 51:825-835.
8. Hakura A, Tsutsui Y, Sonoda J, Kai J, Imade T, Shimada M, Sugihara Y, Mikami T. 1998. Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta Mouse). Mutat Res 398:123-130.
9. Horibata K, Ukai A, Koyama N, Takagi A, Kanno J, Kimoto T, Miura D, Hirose A, Honma M. 2011. Fullerene (C60) is negative in the in vivo Pig-A gene mutation assay. Genes Environ 33:27-31.
10. ICH. 2011. The ICH S2(R1) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. International Conference on Harmonisation. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S2_R1/Step4/S2R1_Step4.pdf.
11. Iscove NN, Sieber F. 1975. Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. Exp Hematol 3:32-43.
12. Jordan CT, Lemischka IR. 1990. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev 4:220-232.
13. Keller P, Tremml G, Rosti V, Bessler M. 1999. X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation. Proc Natl Acad Sci USA 96:7479-7483.
14. Kimoto T, Suzuki K, Kobayashi XM, Dobrovolsky VN, Heflich RH, Miura D, Kasahara Y. 2011. Manifestation of Pig-a mutant bone marrow erythroids and peripheral blood erythrocytes in mice treated with N-ethyl-N-nitrosourea: Direct sequencing of Pig-a cDNA from bone marrow cells negative for GPI-anchored protein expression. Mutat Res 723:36-42.
15. Lambert IB, Singer TM, Boucher SE, Douglas GR. 2005. Detailed review of transgenic rodent mutation assays. Mutat Res 590:1-280.
16. TM mouse. Environ Mol Mutagen 52:756-765.
17. Lynch AM, Giddings A, Custer L, Gleason C, Henwood A, Aylott M, Kenny J. 2011. International Pig-a gene mutation assay trial (Stage III): Results with N-methyl-N-nitrosourea. Environ Mol Mutagen 52:699-710.
18. Miura D, Dobrovolsky VN, Kasahara Y, Katsuura Y, Heflich RH. 2008a. Development of an in vivo gene mutation assay using the endogenous Pig-A gene. I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat. Environ Mol Mutagen 49:614-621.
19. Miura D, Dobrovolsky VN, Mittelstaedt RA, Kasahara Y, Katsuura Y, Heflich RH. 2008b. Development of an in vivo gene mutation assay using the endogenous Pig-A gene. II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ Mol Mutagen 49:622-630.
20. Miura D, Dobrovolsky VN, Kimoto T, Kasahara Y, Heflich RH. 2009. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat Res 677:86-92.
21. Nakajima M, Kikuchi M, Saeki K, Miyata Y, Terada M, Kishida F, Yamamoto R, Furihata C, Dean SW. 1999. Mutagenicity of 4-nitroquinoline 1-oxide in the MutaMouse. Mutat Res 444:321-336.
22. Nohmi T, Suzuki T, Masumura K. 2000. Recent advances in the protocols of transgenic mouse mutation assays. Mutat Res 455:191-215.
23. Nowosaid P, Collins JE, Giddings A, Aylott MC, Sumption ND, Lad A, Rees BJ, Dertinger SD, Kenny JD. 2011. Pig-a mutation assay: Enhancing flow cytometric throughput and statistical power through immunomagnetic wild type depletion. Mutagenesis 27:132.
24. OECD488. 2011. Test guideline 488: OECD guideline for the testing of chemicals. Transgenic rodent somatic and germ cell gene mutation assays. Paris: Organisation for Economic Cooperation and Development.
25. Phonethepswath S, Bryce SM, Bemis JC, Dertinger SD. 2008. Erythrocyte-based Pig-a gene mutation assay: Demonstration of cross-species potential. Mutat Res 657:122-126.
26. Phonethepswath S, Franklin D, Torous DK, Bryce SM, Bemis JC, Raja S, Avlasevich S, Weller P, Hyrien O, Palis J, Macgregor JT, Dertinger SD. 2010. Pig-a mutation: Kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol Sci 114:59-70.
27. Schuler M, Gollapudi BB, Thybaud V, Kim JH. 2011. Need and potential value of the Pig-ain vivo mutation assay-A hesi perspective. Environ Mol Mutagen 52:685-689.
28. Shi J, Krsmanovic L, Bruce S, Kelly T, Paranjpe M, Szabo K, Arevalo M, Atta-Safoh S, Debelie F, LaForce MK, Sly J, Springer S. 2011. Assessment of genotoxicity induced by 7, 12-dimethylbenz(a)anthracene or diethylnitrosamine in the Pig-a, micronucleus and Comet assays integrated into 28-day repeat dose studies. Environ Mol Mutagen 52:711-720.
29. Suzuki T, Itoh S, Nakajima M, Hachiya N, Hara T. 1999. Target organ and time-course in the mutagenicity of five carcinogens in MutaMouse: A summary report of the second collaborative study of the transgenic mouse mutation assay by JEMS/MMS. Mutat Res 444:259-268.